Hjem › Myelofibrose › Florida › Miami
Myelofibrose kliniske forsøg i Miami, FL
10 studier for Myelofibrose søger deltagere på steder i og omkring Miami (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
RekruttererFase 1/2
- University of Miami, Miami
- Baptist Health - Miami Cancer Institute, Miami
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
RekruttererFase 3
- Miami NS Ins Baptist Health S FL, Miami
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
RekruttererFase 3
- Bioresearch Partners, Miami
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RekruttererFase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RekruttererFase 1/2
- Sylvester Cancer Center - U Miami, Miami
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RekruttererFase 1
- University of Miami, Miami
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RekruttererFase 1
- University of Miami Health System, Miami
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekruttererFase 2
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservationsstudie
- Massive Bio SYNERGY-AI site, Miami
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
RekruttererFase 3
- University of Miami, Miami
Myelofibrose forsøg i andre byer
- Houston, TX19 studier
- New York City, NY18 studier
- Boston, MA12 studier
- Durham, NC12 studier
- Columbus, OH11 studier
- Seattle, WA11 studier
- Salt Lake City, UT10 studier
- Nashville, TN9 studier
- Cleveland, OH9 studier
- Tampa, FL9 studier
- Atlanta, GA9 studier
- Baldwin Park, CA9 studier
Andre studier i Miami
- Brystkræft42 studier
- Kræft (alle typer)36 studier
- Ikke-småcellet lungecancer31 studier
- Prostatakræft27 studier
- Overvægt27 studier
- Akut myeloid leukæmi24 studier
- Metastatisk cancer24 studier
- Ægstockræft23 studier
- Overvægt23 studier
- Multipelt myelom21 studier
- Ulcerøs colitis21 studier
- Alzheimers sygdom20 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.